Board approves re-appointment of CEO, Chairman & Managing Director and Whole-time Director
KIMS board has approved re-appointments of three senior leaders.
By ScoutQuest · · 3 min read
- CEO re-appointment term
- further term of 5 years, effective 18th January 2027
- CMD re-appointment term
- further term of five years, effective 01st April 2027
- Whole-time Director re-appointment
- 5 years, effective 01st April 2027
What the board approved
The Board of Directors of Krishna Institute of Medical Sciences Limited, at its meeting held on November 04, 2026, approved three re-appointments based on the recommendation of the Nomination & Remuneration Committee. All three are continuations of existing leadership roles, not new appointments.
- Dr. Abhinay Bollineni (DIN No. 01681273): re-appointed as Director & CEO for a further term of 5 years, with effect from 18th January 2027, for a period of 60 Months.
- Dr. Bhaskara Rao Bollineni (DIN No. 00008985): re-appointed as Chairman & Managing Director for a further term of five years, with effect from 01st April 2027, for a period of 60 Months. This includes continuation in office beyond the age of 70 years.
- Ms. Dandamudi Anitha (DIN No. 00025480): re-appointed as Whole-time Director for a term of 5 years, with effect from 01st April 2027, for a period of 60 Months.
Who these people are
- Dr. Abhinay Bollineni is an Executive Director & CEO of the Company. He holds a bachelor's degree in medicine and a bachelor's degree in surgery from Dr. NTR University of Health Sciences, Andhra Pradesh (Faculty of Modern Medicine) through Deccan College of Medical Sciences. He has been associated with the Company since 2013 and has been spearheading Strategy & Marketing for the entire Group in 2015. He was appointed as CEO in the year 2019 and was named in Business World's "BW 40 Under 40" list in 2019. Under his stewardship, KIMS Hospitals got successfully listed on the Stock Exchanges in India in 2021.
- Dr. Bhaskar Rao Bollineni is one of the promoters of the Company and has been associated with the Company for more than 23 years. He has been instrumental in scripting the phenomenal growth and success of the Company. KIMS Hospital is one of the leading Healthcare Brand in Telangana and Andhra Pradesh with a consistent track record of growth.
- Ms. Anitha Dandamudi is a Whole-time Director of the Company. She holds a diploma in business management from the ICFAI University and a certification for the six-sigma green belt. She also holds certifications for the auditing of quality systems as per ISO 9001-2000 and ISO 9004-2000, and has completed a training program on internal quality audit for the NABH. She has over 17 years of experience in the healthcare industry, having held various positions with the Company.
Family relationships disclosed
- Dr. Abhinay Bollineni is the son of Dr. B. Bhaskara Rao, CMD, and the brother of Mr. Adwik Bollineni, Executive Director of the Company.
- Dr. Bhaskara Rao Bollineni is the father of Dr. Abhinay Bollineni and Adwik Bollineni, Executive Directors of the Company.
- Ms. Anitha Dandamudi: no relationship disclosed against her name.
What this means for a retail investor
The update points to continuity at the top. The same three people stay in the same roles, with fresh terms starting on 18th January 2027 and 01st April 2027. Two of the three key positions are held by promoter-family members, which is disclosed through the relationship details. The update does not include remuneration terms or any financial impact.
Also from Krishna Institute of Medical Sciences
QIP utilisation: NIL deviation or variation for quarter ended 30 September 2026
4 Nov 2026
Nil deviation in use of warrant proceeds for quarter ended 30 September 2026
4 Nov 2026
Monitoring Agency Report: Rs. 150 crore warrant money received, nil utilised in Q2
4 Nov 2026
More numbers
- Re-appointment term - Dr. Abhinay Bollineni (Director & CEO)60 Months
- Re-appointment term - Dr. Bhaskara Rao Bollineni (CMD)60 Months
- Re-appointment term - Ms. Dandamudi Anitha (Whole-time Director)60 Months
- Age limit for continuation in office (CMD)70 years
- Dr. Bhaskar Rao Bollineni's association with the Company23 years
- Ms. Anitha Dandamudi's experience in healthcare industry17 years
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.